Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b).  
 
Medicare does not pay for low vision aids. This exclusion includes all devices that use one or more lenses to 
aid vision or magnify images. This rule applies no matter the size, form or technological features of the device. 
This rule does not apply to:  
 
1. post-surgical prosthetic lenses after surgery in which the lens of the eye was removed;  
 
2. prosthetic intraocular lenses (IOLs) and one pair of conventional eyeglasses or contact lenses furnished after 
each cataract surgery with insertion of an IOL; and  
 
3. prosthetic lenses used by those who are lacking the natural lens of the eye and who were not furnished with 
an IOL.  
You can find this rule at 42 CFR Section 411.15(b). 
  
 
  Medicare does not pay for eye exams for the purpose of prescribing, fitting, or changing eyeglasses or contact 
lenses for refractive error only. Medicare does not pay for procedures performed in the course of any eye exam 
to determine the refractive state of the eyes. Refractive procedures are not covered even when done in 
connection with otherwise covered diagnosis or treatment of illness or injury. You can find these rules at 42 
CFR Section 411.15(c).  
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that the Plan covers items and services in accordance with Medicare rules. The Plan contract also 
says that there is a $1000 deductible which applies to certain items and services. The Plan deductible applies to 
an eye examination, contact lens evaluation, fundus photography, and an eye refraction. The Plan contract also 
says that the deductible does not apply to non-Medicare covered vision eyewear. The Plan contract also says 
that there is a $0 copayment for eyeglasses (lenses and frames) when received out-of-network. You can find 
this information on pages 58-59 and 139-142 of the Plan's 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that percutaneous left atrial appendage closure (LAAC) for non-valvular atrial fibrillation 
(NVAF) through Coverage with Evidence Development (CED) may be covered when the procedure is 
performed by an interventional cardiologist(s), electrophysiologist(s), or cardiovascular surgeon (s) that meet 
the following criteria: 
- Has received training prescribed by the manufacturer on the safe and effective use of the device prior to 
performing LAAC; and, 
- Has performed at least 25 interventional cardiac procedures that involve transeptal puncture through an 
intact septum; and, 
- Continues to perform at least 25 interventional cardiac procedures that involve transeptal puncture 
through an intact septum, of which at least 12 are LAAC, over a 2-year period. 
You can find this information in National Coverage Determination (NCD): Percutaneous Left Atrial 
Appendage Closure (LAAC). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 66-67 in the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that a test panel is a single test with multiple components and is characterized by a single unit of 
service (UOS =1). A panel cannot be unbundled and billed as individual components regardless of the fact that 
the test reports multiple individual pathogens and/or targets. You can find this rule in the Local Coverage 
Article (LCA) for Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen 
Identification Testing (A58761). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
The rules say that definitive testing to confirm a negative presumptive urine drug test (UDT) result, upon the 
order of the clinician, is reasonable and necessary in the following circumstances: 
a. The result is inconsistent with a patients self-report, presentation, medical history, or current 
prescribed medication plan (should be present in the sample); 
b. Following a review of clinical findings, the clinician suspects use of a substance that is 
inadequately detected or not detected by a presumptive UDT; or 
c. When there is an unexpected negative presumptive UDT result, and it is clinically imperative to 
know if it is truly positive or negative; the medical record should state such. 
You can find the rules in Local Coverage Determination (LCD) Urine Drug Testing L36707. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
 
The rules say that definitive urine drug testing (UDT) may be reasonable and necessary based on patient 
specific indications, including historical use, medication response, and clinical assessment, when accurate 
results are necessary to make clinical decisions. To establish that a test is reasonable and necessary, the 
clinicians rationale for the definitive UDT and the tests ordered must be documented in the patients medical 
record. You can find this rule in Local Coverage Determination (LCD) Urine Drug Testing L36707. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that, for services paid on a fee schedule, Medicare secondary payment amounts are determined 
by a formula and are the lowest of: 
1) Excess of the actual charge minus the primary payment; 
2) The amount Medicare would pay if the services were not covered by a primary payer; 
3) The higher of the Medicare payment amount or the primary payers allowable charge minus the amount 
actually paid by the primary payer. 
 
You can find this information in 42 CFR Section 411.33. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
  
  The rules says that the initial thermal radiofrequency ablation (RFA) may be considered medically reasonable 
and necessary after the patient has had at least two medically reasonable and necessary diagnostic medial 
branch blocks (MBBs), with each one providing a consistent minimum of 80% sustained relief of primary 
(index) pain (with the duration of relief being consistent with the agent used). You can find this information in 
Local Coverage Determination (LCD): Facet Joint Interventions for Pain Management (L35936). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that prescription drugs used in immunosuppressive therapy furnished are covered for an 
individual who receives an organ transplant for which payment is made under Medicare. You can find this rule 
in the Social Security Act, Section 1861(s)(2)(J). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that screening tests are excluded from coverage. The only exceptions are for the following 
services: 
 
1. screening mammography,  
2. colorectal cancer screening tests, 
3. screening pelvic exams,  
4. prostate cancer screening tests,  
5. glaucoma screening exams,  
6. ultrasound screening for abdominal aortic aneurysms (AAA),  
7. cardiovascular disease screening tests,  
8. diabetes screening tests, and 
9. screening electrocardiograms, and 
10. certain other testing recommended by the United States Preventive Services Task Force and approved by 
the Centers for Medicare and Medicaid Service. 
 
You can find this rule at 42 CFR Section 411.15(a)(1) and 42 CFR Section 410.64. 
 
The rules state that routine screening and prophylactic testing for lipid disorder are not covered by Medicare. 
While lipid screening may be medically appropriate, Medicare by statute does not pay for it. Lipid testing in 
asymptomatic individuals is considered to be screening regardless of the presence of other risk factors such as 
family history, tobacco use, etc. You can find these rules in National Coverage Determination (NCD) Lipid 
Testing (190.23). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
The rules say that a Epidural steroid injection (ESI) will be considered medically reasonable and necessary 
when the following three (3) requirements are met: 
1. History, physical examination, and concordant radiological image-based diagnostic testing supporting 
one of the following
5
: 
 Lumbar, cervical or thoracic radiculopathy, radicular pain and/or neurogenic claudication due to 
disc herniation, osteophyte or osteophyte complexes, severe degenerative disc disease, producing 
foraminal or central spinal stenosis
5
; OR 
 Post-laminectomy syndrome
6-8
; OR 
 Acute herpes zoster associated pain
6
 
AND 
2. Radiculopathy, radicular pain and/or neurogenic claudication is severe enough to greatly impact quality 
of life or function. An objective pain scale or functional assessment must be performed at baseline 
(prior to interventions). The same scale* must be repeated at each follow-up for assessment of response. 
AND 
3. Pain duration of at least four (4) weeks, and the inability to tolerate noninvasive conservative care or 
medical documentation of failure to respond to four (4) weeks of noninvasive conservative care or 
acute herpes zoster refractory to conservative management where a four (4) week wait is not required. You can find this information in the Local Coverage Determination (LCD): Epidural Steroid Injections for Pain 
Management (L39036). 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that continued coverage of a positive airway pressure (PAP) device (E0470 or E0601) beyond 
the first three months of therapy requires that, no sooner than the 31st day but no later than the 91st day after 
initiating therapy, the treating practitioner must conduct a clinical re-evaluation and document that the 
beneficiary is benefiting from PAP therapy. Documentation of clinical benefit is demonstrated by: 
 
1. In-person clinical re-evaluation by the treating practitioner with documentation that symptoms of obstructive 
sleep apnea are improved; and, 
2. Objective evidence of adherence to use of the PAP device, reviewed by the treating practitioner. 
 
Adherence to therapy is defined as use of PAP greater than or equal to 4 hours per night on 70% of nights 
during a consecutive thirty (30) day period anytime during the first three (3) months of initial usage. You can 
find this information in the Local Coverage Determination (LCD): Positive Airway Pressure (PAP) Devices for 
the Treatment of Obstructive Sleep Apnea (L33718). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
The rules say that the following are indications for wireless capsule endoscopy: 
 For investigating suspected small intestinal bleeding in persons with objective evidence of recurrent, 
obscure GI bleeding (e.g., persistent or recurrent iron-deficiency anemia and/or persistent or recurrent positive 
fecal occult blood test (FOBT), or visible bleeding) who have had upper and lower GI endoscopies within the 
past 12 months (esophagogastroduodenoscopy (EGD) and colonoscopy) that have failed to identify a bleeding 
source; 
 
 For evaluation of regional non-metastatic carcinoid tumors of the small bowel in persons with carcinoid 
syndrome; 
 
 For evaluation of persons with celiac disease with a positive serology and negative biopsy; 
 
 For re-evaluation of persons with celiac disease who remain symptomatic despite treatment and there is no 
suspected or confirmed GI obstruction, stricture, or fistulae; 
 
 For initial diagnosis in persons with suspected Crohn's disease (abdominal pain or diarrhea plus 1 or more 
signs of inflammation (e.g., fever, elevated white blood cell (WBC) count, elevated erythrocyte sedimentation 
rate, or bleeding) without evidence of disease on conventional diagnostic tests, including small-bowel follow-
through or abdominal computed tomography (CT) scan/CT enterography and upper and lower endoscopy 
(EGD and colonoscopy); 
 
 For re-evaluation of persons with Crohn's disease who remain symptomatic despite treatment and there is no 
suspected or confirmed GI obstruction, stricture, or fistulae; 
 
 For surveillance of small intestinal tumors in persons with Lynch syndrome, Peutz-Jeghers syndrome and 
other polyposis syndromes affecting the small bowel; or  
 
 For screening or surveillance of esophageal varices. You can find this rule at Local Coverage Determination (LCD) L36427: Wireless Capsule Endoscopy (eff. 
10/28/21). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Pneumatic Compression Device (PCD) that provides intermittent limb compression for the 
purpose of prevention of venous thromboembolism (E0676) is a preventive service. Items that are used for a 
preventative service or function are excluded from coverage under the Medicare Durable Medical Equipment 
(DME) benefit. There is insufficient evidence to demonstrate that reimbursement is justified. You can find this 
information in the Local Coverage Article: Pneumatic Compression Devices - Policy Article (A52488) and in 
the Local Coverage Determination (LCD): Pneumatic Compression Devices (L33829). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
The rules say a second diagnostic facet procedure is considered medically necessary to confirm validity of the 
initial diagnostic facet procedure when administered at the same level. The second diagnostic procedure may 
only be performed a minimum of 2 weeks after the initial diagnostic procedure. Clinical circumstances that 
necessitate an exception to the two-week duration may be considered on an individual basis and must be clearly 
documented in the medical record. 
For the first diagnostic facet joint procedure: 
a. For the first diagnostic facet joint procedure to be considered medically reasonable and 
necessary, the patient must meet the criteria outlined under indications for facet joint 
interventions. 
b. A second confirmatory diagnostic facet joint procedure is considered medically reasonable and 
necessary in patients who meet ALL the following criteria: 
i. The patient meets the criteria for the first diagnostic procedure; AND 
ii. After the first diagnostic facet joint procedure, there must be a consistent positive 
response of at least 80% relief of primary (index) pain (with the duration of relief being 
consistent with the agent used)  
You can find this information in the Local Coverage Determination (LCD): Facet Joint Interventions for Pain 
Management (L38803). If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.